What antiepileptic prophylaxis regimen (drug, dose, and duration) is recommended for patients with moderate to severe traumatic brain injury (Glasgow Coma Scale ≤12) or intracranial hemorrhage?

Antiepileptic Prophylaxis in Head Injury

Routine antiepileptic drug (AED) prophylaxis is NOT recommended for patients with moderate to severe traumatic brain injury or intracranial hemorrhage, as it does not prevent late seizures and may worsen neurological outcomes. 1

Key Recommendation

The 2018 severe TBI management guidelines explicitly state: "We do not suggest using antiepileptic drugs for primary prevention to reduce the incidence of post-traumatic seizures (early and delayed)" (Grade 2-, Strong Agreement) 1. This recommendation is based on 11 clinical trials involving over 2,700 patients that showed no significant effect of AEDs in preventing early or delayed post-traumatic seizures, with evidence of increased side effects and potential worsening of neurological outcomes 1.

The most recent 2024 Neurocritical Care Society guidelines for TBI reinforce this position, stating that ASM or no ASM may be used (weak recommendation, low quality evidence), acknowledging the lack of clear benefit 2. Similarly, the 2025 guidelines for nontraumatic ICH suggest avoidance of prophylactic ASM due to increased adverse events and higher risk of poor functional outcomes at 90 days 3.

When to Consider AED Use

High-Risk Scenarios Where Prophylaxis MAY Be Considered:

• Chronic subdural hematoma 1
• Past history of epilepsy 1
• Craniectomy (identified as risk factor for early seizures) 1
• Brain contusion, acute subdural hematoma, skull fracture, or loss of consciousness >24 hours 1

If You Choose to Use an AED:

Drug Selection:

• Levetiracetam is preferred over phenytoin/fosphenytoin due to better tolerance and fewer side effects 1, 2
• Phenytoin showed increased side effects and potential worsening of neurological outcomes in multiple studies 1

Dosing:

• Levetiracetam: 500-1000 mg twice daily (total daily dose ≤1000-2000 mg) 4, 5
• Interestingly, recent data suggests that lower doses (≤1000 mg/day) may have lower seizure rates than higher doses, though this remains controversial 5
• Standard dosing is typically 500 mg IV/PO twice daily

Duration:

• ≤7 days maximum 2, 3
• Longer duration is associated with worse cognitive outcomes and increased adverse events without preventing late seizures 1, 2
• No benefit for preventing late post-traumatic seizures (occurring >7 days after injury) has been demonstrated 6

Evidence Nuances

The Phenytoin Data:

While older studies (including a 2003 practice parameter) showed phenytoin reduces early seizures (within 7 days) with a relative risk of 0.37 6, this benefit does NOT translate to:

• Prevention of late seizures
• Improved functional outcomes
• Reduced mortality

In fact, phenytoin prophylaxis was associated with worse outcomes in ICH patients 7.

The Seizure Risk Context:

• Early clinical seizures (within 7 days): 2.2% incidence in general TBI population
• Delayed seizures: 2.1% overall, but 11.9% in first year for severe TBI 1
• These relatively low rates must be weighed against the potential harms of prophylactic treatment

Active Seizure Management (Different from Prophylaxis)

If actual seizures occur or are suspected:

• Treat active seizures aggressively with appropriate AEDs
• Consider continuous EEG monitoring for ≥24-48 hours in patients with:
  • Impaired/fluctuating consciousness out of proportion to injury
  • No clear clinical seizure activity but concerning examination 7
• 28% of electrographic seizures detected after 24 hours of monitoring; 94% by 48 hours 7

Common Pitfalls to Avoid

1. Don't reflexively start prophylactic AEDs just because there's intracranial hemorrhage—the evidence doesn't support routine use
2. Don't continue AEDs beyond 7 days for prophylaxis—no benefit and potential cognitive harm
3. Don't use valproate—limited evidence and not preferred over levetiracetam or phenytoin
4. Don't assume preventing early seizures prevents late epilepsy—the data clearly shows no connection 1, 6

Clinical Decision Algorithm

Patient with moderate-severe TBI/ICH
↓
Has patient had actual seizure? 
├─ YES → Treat seizure, consider continuous EEG
└─ NO → Assess risk factors
    ↓
    High-risk features present?
    (craniectomy, chronic SDH, prior epilepsy, severe contusion)
    ├─ YES → MAY consider levetiracetam 500 mg BID × ≤7 days
    └─ NO → No prophylactic AED recommended

The weight of current evidence favors a conservative approach, reserving AEDs for treatment of actual seizures rather than prophylaxis, given the lack of benefit for meaningful outcomes and potential for harm.